KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 189 filers reported holding KRYSTAL BIOTECH INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $483,836 | +0.1% | 4,171 | +1.3% | 0.02% | 0.0% |
| Q2 2023 | $483,453 | -62.5% | 4,118 | -74.4% | 0.02% | -62.8% |
| Q1 2023 | $1,289,366 | +1.0% | 16,105 | -0.1% | 0.04% | -21.8% |
| Q4 2022 | $1,277,185 | -14.2% | 16,122 | -24.5% | 0.06% | -20.3% |
| Q3 2022 | $1,489,000 | +6.5% | 21,358 | +0.3% | 0.07% | +7.8% |
| Q2 2022 | $1,398,000 | -14.9% | 21,284 | -13.4% | 0.06% | -1.5% |
| Q1 2022 | $1,643,000 | -31.0% | 24,565 | -27.8% | 0.06% | -26.1% |
| Q4 2021 | $2,381,000 | +735.4% | 34,036 | +524.1% | 0.09% | +700.0% |
| Q3 2021 | $285,000 | -23.2% | 5,454 | 0.0% | 0.01% | -31.2% |
| Q2 2021 | $371,000 | -11.7% | 5,454 | 0.0% | 0.02% | -20.0% |
| Q1 2021 | $420,000 | +28.4% | 5,454 | 0.0% | 0.02% | +11.1% |
| Q4 2020 | $327,000 | +39.1% | 5,454 | 0.0% | 0.02% | +20.0% |
| Q3 2020 | $235,000 | +4.4% | 5,454 | 0.0% | 0.02% | 0.0% |
| Q2 2020 | $225,000 | – | 5,454 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $53,700,000 | 4.14% |
| S Squared Technology, LLC | 85,215 | $5,113,000 | 2.93% |
| First Light Asset Management, LLC | 491,740 | $29,504,000 | 2.18% |
| Redmile Group, LLC | 1,675,036 | $100,502,000 | 1.22% |
| Nicholas Investment Partners, LP | 233,543 | $14,013,000 | 1.08% |
| HighMark Wealth Management LLC | 17,586 | $1,055,000 | 0.91% |
| DSAM Partners (London) Ltd | 87,608 | $5,256,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 101,044 | $6,063,000 | 0.54% |
| Hood River Capital Management LLC | 261,122 | $15,667,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 9,900 | $594,000 | 0.45% |